For clinicians
If you care for patients with PSP, CBD, MSA or another rare neurodegenerative disease, you can tell them about Cortau.
Who to refer
- Patients with any disease on our list, or an undiagnosed progressive neurological disease
- Families of patients who have died, especially after a brain donation
- Patients who already had exome or genome sequencing
What we ask of you
Nothing beyond the referral. Patients and families sign up and consent themselves. With their permission, we may contact you to confirm a diagnosis.
What participants get
Participation is research, not clinical testing. Results are only returned when confirmed by a CLIA-certified laboratory, and only to participants who ask for them.
To request printed materials, email contact@cortau.com.